Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Oct 09, 2019 | Chief People Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 6,896 | $7.48 | 101,161 | |
| Jul 07, 2009 | Director, President & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 5,788 | $11.15 | 100,448 | |
| Jul 07, 2009 | Director, President & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 412 | $11.69 | 100,036 | |
| Apr 12, 2018 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 5,000 | -- | 100,000 | |
| Jan 04, 2016 | Chief Operating Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 50,000 | -- | 100,000 | |
| Jan 04, 2016 | Chief Operating Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 100,000 | -- | 100,000 | |
| Jun 01, 2015 | Chief Operating Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 100,000 | -- | 100,000 | |
| Mar 20, 2015 | Chief Financial Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 15,235 | $11.51 | 100,000 | |
| Nov 25, 2014 | Chief Financial Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 10,000 | $8.00 | 100,000 | |
| Oct 03, 2014 | Chief Financial Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 10,000 | $7.00 | 100,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.